I am reading a book on IPOs and building a database of past and current IPOs and ran across this earlier today.
"At the core of its cardiovascular solutions is a proprietary Integrated Genetic-Epigenetic Engine™ created at the University of Iowa by company founders Meesha Dogan, Ph.D., and Robert Philibert, MD, Ph.D. This technology enables the development of a series of tests for precision prevention, early detection, and assists in personalized treatment of major types of cardiovascular diseases and associated co-morbidities."
I have no idea if this will amount to anything as a stock but will update this if anything interesting happens
Ticker symbol will be CDIO
"At the core of its cardiovascular solutions is a proprietary Integrated Genetic-Epigenetic Engine™ created at the University of Iowa by company founders Meesha Dogan, Ph.D., and Robert Philibert, MD, Ph.D. This technology enables the development of a series of tests for precision prevention, early detection, and assists in personalized treatment of major types of cardiovascular diseases and associated co-morbidities."
I have no idea if this will amount to anything as a stock but will update this if anything interesting happens
Ticker symbol will be CDIO
Cardio Diagnostics Holdings, Inc. to List on Nasdaq Following Successful Business Combination with Mana Capital Acquisition Corp.
CHICAGO, October 26, 2022--Cardio Diagnostics Holdings, Inc. ("Cardio" or the "Company"), a pioneering precision cardiovascular medicine company at the intersection of epigenetics and artificial intelligence whose products enable improved prevention, early detection and treatment of...
finance.yahoo.com